Medical Marijuana Clinical Trials Creating New Opportunities for Producing Therapeutic Medicines for Future FDA & INVIMA Applications

CORAL SPRINGS, Florida, November 5, 2014 /PRNewswire/ --

Cannabis industry forecasts billions in revenue as United States moves towards legalization and MMJ Companies focus on new plans, joint ventures and development of innovative Marijuana products.  Companies in Focus Today are: New Colombia Resources, Inc. (OTCQB: NEWC), Neutra Corp. (OTC: NTRR), Creative Edge Nutrition, Inc. (OTC: FITX), Tauriga Sciences, Inc. (OTC: TAUG) and Cannabis Science, Inc. (OTC: CBIS).

New Colombia Resources, Inc. (OTCQB: NEWC) ("New Colombia or the Company"), a U.S. company with coal and other resource assets in Colombia, is pleased to announce plans to spin out its Sannabis S.A.S medical hemp based products company and create an independent U.S. traded reporting publicly traded company. John Campo, President, stated: "Our management team is focused on our core business of developing company coal reserves and industrial aggregate operations. By allowing Sannabis SAS to become an independent public company it will be able to develop its own medical based management team. Additionally Sannabis will have one mission the development of its innovative medical products based on scientific research using unique strains of Cannabis manufactured on the TOEZ Indian Reservation in Colombia. The Company plans to issue shares of Sannabis S.A.S. as a dividend to Shareholders.

Read the full NEWC press release at http://www.financialnewsmedia.com/profiles/newc.html

After the spinoff Sannabis S.A.S. will operate as an independent company and develop its own medical research staff and funding to further the commercialization of its products.  Sannabis S.A.S. aims to become the first company to legally import hemp and medical marijuana products to the U.S. from Colombia. Operations will include patent applications, obtaining medical approvals, and further research and product development.  Sannabis SAS believes that the specific strain of hemp being produced on the TOEZ Indian reservation may creates a unique medical opportunity for many people who may find benefit from various hemp based product derivates. 

Neutra Corp. (OTCQB: NTRR) recently announced it is finalizing plans for its first commercial production run of the cutting-edge Diamond Anvil Vapor Pen just as analysts are predicting the cannabis industry will not only be legal, but have more annual revenue than the NFL by 2020. Greenwave Advisors, a cannabis-focused research and analysis firm, recently projected federal legalization of the herb in the next six years, which would push first-year countrywide revenues to an estimated $35 billion, surpassing the annual revenue of the NFL. Even without full federal legalization, Greenwave still projects $21 billion in legal cannabis revenues, however, the firm believes 12 states and the District of Columbia will have legalized recreational cannabis by 2020, with medical cannabis being available in 37 states. Currently 23 states have legalized medical cannabis and two states have legalized recreational cannabis use.

Creative Edge Nutrition, Inc. (OTCPink: FITX), a nutritional supplement company, develops, markets, and sells nutraceuticals and health supplements. It offers a range of capsules, tablets, and powders, as well as science based products in weight management, specific nutrition challenges, energy, and fitness categories. The company's products comprise HYPER INFUSION, a pre work-out catalyst; AMINO PLEX, a intra-workout recovery catalyst; CENTRO PLEX, an advanced meal replacement product; ALPHA DRIVE to enhance free testosterone levels; VASOBOLIC, a stimulant free nitric oxide pre-cursor; INOVA, a pre-workout supplement; REDEMPTION; FREE REIGN to increase free testosterone; ROGUE, a muscle builder; THYROZINE, a mood elevating thermogenic; HYPE, a high intensity thermogenic; and REGIME, a physique enhancement product. It also provides natural products, such as Hemp Nutra tea, coffee additives, and slimming tea. On Tuesday, FITX closed up 2.7% on over 19.1 million shares traded.

Tauriga Sciences, Inc. (OTCQB: TAUG), a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, announced that it has signed a non-binding MOU with Japan-based iFlow, Ltd. ("iFlow") to distribute and sell three new Tauriga-branded natural wellness products to the Japan, Taiwan and Hong Kong regions (the "Territory"). iFlow is an innovative and entrepreneurial Asian marketing and distribution company with motivational products in health, lifestyle, education, business and finance. If a definitive agreement is reached, the partnership between the companies would enable Tauriga to reach Asian customers with an interest in natural healing. The intent of the parties is for the initial focus of the partnership to be on two different formulations of Tauriga's proprietary TopiCanna topical cannabis cream and on Tauriga's CannaCaviar brand of small soft gel supplements. In compliance with Japanese medical marijuana law, all three products would use oil that has been extracted from the stalk of the cannabis plant and that is higher in CBD (cannabidiol) and low in THC, hence providing wellness and healing properties without psychoactive effects. If the initial phase of the proposed partnership is successful in establishing the Tauriga natural wellness brand in the Territory, the two companies plan to extend the agreement to include additional Tauriga products, such as Tauriga's new line of natural dietary supplements.

Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting is very pleased with the laboratory analytical reports it recently received. The testing of the cannabis harvested using EU certified as well as its own unique strains produced end results indicating that whole extracts to be produced will contain upward of 20% CBD and less than 10% THC. Furthermore, other unique identifiers are present that require multiple authentications based on their significant nature. These numbers are significant based on usage information and expected treatment regimes for many of the Company targeted ailments. The Company continues investigating both its unique cannabinoid strains as well as promising strains from around the world for multiple pre-clinical drug development programs targeting Cancer, Neurological Disorders, and a few other targeted critical ailments to be announced.

FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services.  If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details.  Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/.  Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter:  http://twitter.com/FNMgroup. 

DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has not been compensated for news coverage of any Companies listed herein. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. 

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company: FN Media Group, LLC
Contact email: [email protected]
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com

SOURCE FN Media Group LLC